The Legislative Analysis and Public Policy Association (LAPPA) has released an updated 50-state summaries report on kratom, an herbal substance that can produce opioid- and stimulant-like effects. The report, Kratom: Summary of State Laws, includes the statutory or regulatory citation(s) on the herb, requirements for product labels, penalties for violations, and more. Kratom and its two psychoactive ingredients, mitragynine and 7-hydroxymitragynine, are neither federally regulated nor considered controlled substances (CS). As of February 2024, however, 22 states and the District of Columbia have placed some types of restrictions on the herb or its components, such as classifying kratom’s ingredients as CS or regulating the possession, sale, and manufacturing process of kratom because of potential adverse effects. A copy of the summary can be found here.